Gordon F. Schwartz

Biochemistry, Genetics and Molecular Biology · Life Sciences

45h-index7.0kcitations170works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Breast Cancer Treatment Studies(94), Breast Lesions and Carcinomas(70), Breast Implant and Reconstruction(26), Global Cancer Incidence and Screening(15), Cancer Diagnosis and Treatment(13)

Publications169 total

Data from Molecular Grading of Ductal Carcinoma <i>In situ</i> of the Breast
2023Open Access
Supplementary Data from Molecular Grading of Ductal Carcinoma <i>In situ</i> of the Breast
2023Open Access
Data from Molecular Grading of Ductal Carcinoma <i>In situ</i> of the Breast
2023Open Access
Supplementary Data from Molecular Grading of Ductal Carcinoma <i>In situ</i> of the Breast
2023Open Access
肺移植後の転帰に対するサルコペニアの影響を評価する単一施設研究【JST・京大機械翻訳】
The Journal of Heart and Lung Transplantation·2019
Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017
Journal of Clinical Oncology·2017· 188 citedOpen Access
Assessment of the Placenta with the Phase Contrast Microscope
2015
OUTPATIENT MEDICATION USE AND IMPLICATIONS FOR DENTAL CARE: GUIDANCE FOR CONTEMPORARY DENTAL PRACTICE.
PubMed·2015· 16 cited
The retinoblastoma tumor suppressor pathway modulates the invasiveness of ErbB2-positive breast cancer
Oncogene·2013· 26 citedOpen Access
Impact of Oncotype DX on Treatment Decisions in ER-Positive, Node-Negative Breast Cancer with Histologic Correlation
The Breast Journal·2013· 25 cited
John Chalmers DaCosta (1863–1933): Restoration of the Old Operating Table
The American Surgeon·2013· 1 cited
Abstract B54: Coordinate RB/PTEN tumor suppressor loss: Drives aggressive invasive behavior and is strongly associated with the progression of ductal carcinoma to invasive breast cancer
Cancer Research·2013
Retinoblastoma and Phosphate and Tensin Homolog Tumor Suppressors: Impact on Ductal Carcinoma In Situ Progression
JNCI Journal of the National Cancer Institute·2012· 28 citedOpen Access
RB-Pathway Disruption Is Associated with Improved Response to Neoadjuvant Chemotherapy in Breast Cancer
Clinical Cancer Research·2012· 68 citedOpen Access
Adjuvant Therapy in Stage I Carcinoma of the Breast: The Influence of Multigene Analyses and Molecular Phenotyping
The Breast Journal·2012· 17 cited
Authors' Reply
Journal of the American College of Radiology·2012
Adjuvant therapy in stage I carcinoma of the breast
Cancer·2012· 7 citedOpen Access
Percutaneous Needle vs Surgical Breast Biopsy: Previous Allegations of Overuse of Surgery Are in Error
Journal of the American College of Radiology·2012· 12 cited
Progression of ductal carcinoma in situ to invasive breast cancer is associated with gene expression programs of EMT and myoepithelia
Breast Cancer Research and Treatment·2011· 108 cited
Table of Contents
American Journal Of Pathology·2011Open Access
page 1 of 9Next →

Frequent Co-authors

Stephen A. Feig(9), Anne Rosenberg(7), Lydia Komarnicky(7), Arthur S. Patchefsky(7), Lawrence J. Solin(7), Ivo A. Olivotto(6), Juan Palazzo(6), Carl M. Mansfield(5), Agnieszka K. Witkiewicz(5), Umberto Veronesi(4), Virginia L. Ernster(4), Gary S. Shaber(4), Kevin S. Hughes(4), Ian S. Fentiman(4), Roland Holland(4), Armando E. Giuliano(3), Gerald C. Finkel(3), Mark E. Robson(3), Terry Hyslop(3), Amory B. Schwartz(3)